TP53 and pituitary gland adenoma: The nonparametric unpaired Kruskal-Wallis test was used to evaluate differences between the two study groups (progressive versus nonprogressive residual pituitary adenoma) in p21, p27, and p53 expression and in the Ki-67 proliferative index.